MGTX Logo

MeiraGTx Holdings plc (MGTX) 

NASDAQ$7.79
Market Cap
$608.81M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
70 of 924
Rank in Industry
49 of 527

MGTX Insider Trading Activity

MGTX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$5,000,000125
Sells
$456,303375

Related Transactions

PERCEPTIVE ADVISORS LLC1$5M0$0$5M
Giroux RichardCFO & COO0$01$150,960$-150,960
Forbes AlexandriaPRESIDENT & CEO0$02$305,343$-305,343

About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, â€¦

Insider Activity of MeiraGTx Holdings plc

Over the last 12 months, insiders at MeiraGTx Holdings plc have bought $5M and sold $456,303 worth of MeiraGTx Holdings plc stock.

On average, over the past 5 years, insiders at MeiraGTx Holdings plc have bought $10.71M and sold $4.12M worth of stock each year.

Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC () — $5M.

The last purchase of 1,250,000 shares for transaction amount of $5M was made by PERCEPTIVE ADVISORS LLC () on 2024‑08‑12.

List of Insider Buy and Sell Transactions, MeiraGTx Holdings plc

2025-01-21SaleGiroux RichardCFO & COO
24,000
0.0304%
$6.29$150,960+2.65%
2025-01-08SaleForbes AlexandriaPRESIDENT & CEO
11,661
0.0148%
$6.30$73,464+1.10%
2025-01-07SaleForbes AlexandriaPRESIDENT & CEO
35,839
0.0469%
$6.47$231,878+1.10%
2024-08-12PurchasePERCEPTIVE ADVISORS LLC
1.25M
1.9341%
$4.00$5M+52.25%
2023-05-05PurchasePERCEPTIVE ADVISORS LLC
4.35M
8.3577%
$5.75$25M-2.03%
2022-06-03PurchaseZeldin Robert KCHIEF MEDICAL OFFICER
6
<0.0001%
$7.89$47-6.73%
2022-05-25PurchaseWollin Robert JGENERAL COUNSEL AND SECRETARY
1,000
0.0022%
$7.94$7,940-5.28%
2021-11-17SaleForbes AlexandriaPresident and CEO
30,000
0.0679%
$19.86$595,800-51.18%
2021-11-16SaleForbes AlexandriaPresident and CEO
30,000
0.0678%
$19.97$599,144-51.10%
2021-10-20SaleGiroux RichardCFO & COO
41,400
0.0941%
$21.05$871,371-40.21%
2021-10-19SaleGiroux RichardCFO & COO
2,600
0.0062%
$20.07$52,182-33.88%
2021-10-18SaleForbes AlexandriaPresident and CEO
60,000
0.1271%
$17.36$1.04M-31.36%
2021-10-18SaleNaylor StuartChief Development Officer
24,000
0.0526%
$17.95$430,800-31.36%
2021-07-20SaleNaylor StuartChief Development Officer
18,780
0.0419%
$15.06$282,827-10.03%
2021-07-13SaleNaylor StuartChief Development Officer
5,220
0.0119%
$15.04$78,509-6.75%
2021-06-09SaleForbes AlexandriaPresident and CEO
8,306
0.0187%
$15.04$124,922-6.21%
2021-06-08SaleForbes AlexandriaPresident and CEO
40,360
0.0917%
$15.02$606,207-5.14%
2021-06-08SaleNaylor StuartChief Development Officer
10,080
0.0229%
$15.01$151,301-5.14%
2021-06-07SaleForbes AlexandriaPresident and CEO
11,334
0.026%
$15.03$170,350-4.05%
2021-06-07SaleNaylor StuartChief Development Officer
2,084
0.0048%
$15.02$31,302-4.05%
Total: 67
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
PERCEPTIVE ADVISORS LLC
12531103
16.034%
$97.62M60<0.0001%
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10 percent owner
6007746
7.6871%
$46.8M10+18.44%
Seligman Nicoledirector
5000
0.0064%
$38,950.0010<0.0001%
Zeldin Robert KCHIEF MEDICAL OFFICER
5000
0.0064%
$38,950.0010<0.0001%
Wollin Robert JGENERAL COUNSEL AND SECRETARY
1000
0.0013%
$7,790.0010<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$3,596,906
112
13.42%
$635.29M
$36,510,315
95
8.95%
$609.56M
$587,109,125
90
3.17%
$527.16M
$678,065,999
37
-13.32%
$603.22M
$94,912,877
34
-7.15%
$626.42M

MGTX Institutional Investors: Active Positions

Increased Positions60+64.52%15M+33.97%
Decreased Positions38-40.86%2M-5.47%
New Positions17New14MNew
Sold Out Positions15Sold Out839,341Sold Out
Total Postitions115+23.66%58M+28.5%

MGTX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Perceptive Advisors Llc$89,703.0016.13%12.58M00%2024-12-31
Sanofi$86,970.0015.64%12.2M+12MNew2024-12-31
Johnson & Johnson$47,351.008.51%6.64M00%2024-12-31
Adage Capital Partners Gp, L.L.C.$35,897.006.46%5.03M-194,521-3.72%2024-12-31
Prosight Management, Lp$31,307.005.63%4.39M-509,733-10.4%2024-12-31
Blackrock, Inc.$21,187.003.81%2.97M+284,774+10.6%2024-12-31
683 Capital Management, Llc$17,219.003.1%2.42M-135,000-5.29%2024-12-31
Woodline Partners Lp$10,945.001.97%1.54M+2MNew2024-12-31
Knoll Capital Management, Llc$8,913.001.6%1.25M00%2024-12-31
Erste Asset Management Gmbh$4,775.000.86%669,70200%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.